Literature DB >> 8071480

Mortality in affective disorder.

R Sharma1, H R Markar.   

Abstract

472 bipolar patients were followed up retrospectively over 17 years. The patients that died were compared with the general population and a control group. The former comparison showed greater mortality from suicide, cardiovascular and respiratory causes in the index population and the latter, that the deceased were more likely to have been unmarried, with greater frequency and duration of admissions, a shorter follow-up period and were less likely to have received lithium treatment. The suicides were significantly younger at onset and death than the index and control groups, and suicide was uncommon where follow-up extended over 10 years.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8071480     DOI: 10.1016/0165-0327(94)90112-0

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  29 in total

1.  Psychopharmacological treatment status in outpatients with bipolar disorder: a clinical survey in Germany.

Authors:  Arnim Quante; Sara Zeugmann; Francesca Regen; Annette Engelhardt; Ion-George Anghelescu
Journal:  Psychiatry Investig       Date:  2010-07-09       Impact factor: 2.505

2.  [Annual costs of bipolar disorders in Germany].

Authors:  C Runge; H Grunze
Journal:  Nervenarzt       Date:  2004-09       Impact factor: 1.214

3.  Evidence for the continuous latent structure of mania in the Epidemiologic Catchment Area from multiple latent structure and construct validation methodologies.

Authors:  J J Prisciandaro; J E Roberts
Journal:  Psychol Med       Date:  2010-05-27       Impact factor: 7.723

Review 4.  The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide prevention.

Authors:  Maurizio Pompili; Gianluca Serafini; Marco Innamorati; Anne Maria Möller-Leimkühler; Giancarlo Giupponi; Paolo Girardi; Roberto Tatarelli; David Lester
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-02-20       Impact factor: 5.270

5.  Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder.

Authors:  Jess G Fiedorowicz; David A Solomon; Jean Endicott; Andrew C Leon; Chunshan Li; John P Rice; William H Coryell
Journal:  Psychosom Med       Date:  2009-06-26       Impact factor: 4.312

6.  Mania and depression in the perinatal period among women with a history of major depressive disorders.

Authors:  Angela J Inglis; Catriona L Hippman; Prescilla B Carrion; William G Honer; Jehannine C Austin
Journal:  Arch Womens Ment Health       Date:  2014-01-09       Impact factor: 3.633

Review 7.  Cardiovascular morbidity and mortality in bipolar disorder.

Authors:  Miriam Weiner; Lois Warren; Jess G Fiedorowicz
Journal:  Ann Clin Psychiatry       Date:  2011-02       Impact factor: 1.567

8.  The association between mood and anxiety disorders with vascular diseases and risk factors in a nationally representative sample.

Authors:  Jess G Fiedorowicz; Jianping He; Kathleen R Merikangas
Journal:  J Psychosom Res       Date:  2010-09-18       Impact factor: 3.006

Review 9.  Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder.

Authors:  Ayal Schaffer; Erkki T Isometsä; Leonardo Tondo; Doris H Moreno; Mark Sinyor; Lars Vedel Kessing; Gustavo Turecki; Abraham Weizman; Jean-Michel Azorin; Kyooseob Ha; Catherine Reis; Frederick Cassidy; Tina Goldstein; Zoltán Rihmer; Annette Beautrais; Yuan-Hwa Chou; Nancy Diazgranados; Anthony J Levitt; Carlos A Zarate; Lakshmi Yatham
Journal:  Aust N Z J Psychiatry       Date:  2015-07-16       Impact factor: 5.744

10.  Pattern of healthcare resource utilization and direct costs associated with manic episodes in Spain.

Authors:  Monica Tafalla; Luis Salvador-Carulla; Jerónimo Saiz-Ruiz; Teresa Diez; Luis Cordero
Journal:  BMC Psychiatry       Date:  2010-04-28       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.